You are here » Home » Companies » Company Overview » Strides Pharma Science Ltd

Strides Pharma Science Ltd.

BSE: 532531	Sector: Health care
NSE: STAR	ISIN Code: INE939A01011

BSE 15:54 | 02 Feb

300.75

16.40
(5.77%)

OPEN

286.35

HIGH

309.80

LOW

286.35

NSE 15:45 | 02 Feb

301.50

16.95
(5.96%)

OPEN

285.80

HIGH

309.85

LOW

285.70

Add to Watchlist | Add to Portfolio

OPEN	286.35
PREVIOUS CLOSE	284.35
VOLUME	35948
52-Week high	413.50
52-Week low	263.45
P/E	19.02
Mkt Cap.(Rs cr)	2,716
Buy Price	300.75
Buy Qty	500.00
Sell Price	0.00
Sell Qty	0.00

OPEN	286.35
CLOSE	284.35
VOLUME	35948
52-Week high	413.50
52-Week low	263.45
P/E	19.02
Mkt Cap.(Rs cr)	2,716
Buy Price	300.75
Buy Qty	500.00
Sell Price	0.00
Sell Qty	0.00

Strides Pharma Science Ltd. (STAR) - News Sector

Sun Pharma Q3 net profit up 5.2% as sales grow in India, US markets

10.36 pm | 31 Jan 2023 | Business Standard

Company says specialty products will continue as growth driver, will scale up investment for it
Laurus Labs slips 5%, hits over 2-year low post December quarter results

3.13 pm | 31 Jan 2023 | Business Standard

Laurus Labs delivered operationally in-line performance, led by healthy traction in CDMO-Synthesis/Non-ARV API segment
Beside Adani Green, Adani Transmission; 14 other stocks hit new 52-week low

11.23 am | 31 Jan 2023 | Business Standard

Whenever a stock hits a new 52-week low, further fall from a medium-term scale appears realistic, with price endorsing further correction of 10 per ce...
Beside Adani Green, Adani Transmission; 14 other stocks hit new 52-week low

11.23 am | 31 Jan 2023 | Business Standard

Whenever a stock hits a new 52-week low, further fall from a medium-term scale appears realistic, with price endorsing further correction of 10 per ce...
Beside Adani Green, Adani Transmission; 14 other stocks hit new 52-week low

11.23 am | 31 Jan 2023 | Business Standard

Whenever a stock hits a new 52-week low, further fall from a medium-term scale appears realistic, with price endorsing further correction of 10 per ce...
Alkem launches novel antibiotic combination for drug-resistant infections

6.24 pm | 30 Jan 2023 | Business Standard

The formulation, to be sold under the Zidavi brans for Rs 2,700 a vial, has been approved by US FDA, European Medicines Agency, and CDSCO
Sun Pharma nears 52-week high ahead of Q3 results; stock up 7% in a month

11.56 am | 30 Jan 2023 | Business Standard

In the past one month, Sun Pharma outperformed market as shares surged 7 per cent, as compared to 2.5 per cent decline in the S&P BSE Sensex
Enzene Biosciences raises $50 million, aims to expand into global markets

12.22 am | 30 Jan 2023 | Business Standard

Enzene said it has built a highly experienced 400-person team under the leadership of Dr. Himanshu Gadgil, CEO at Enzene Biosciences Ltd
Flows to Indian equities are at risk as investors eye China: Chris Wood

10.55 pm | 27 Jan 2023 | Business Standard

He believes India remains the best long-term equity story in Asian and the emerging market (EM) context
Torrent Pharma Q3 PAT up 14% to Rs 249 crore riding on India, Brazil

10.45 pm | 25 Jan 2023 | Business Standard

Torrent Pharma's revenues came in at Rs 2,491 crore for the quarter under review. The Ebitda margins were at 29.1 per cent while gross margins were 71...
DRL posts strong 77% profit growth to Rs 1,247 cr riding on US, Russia

6.59 pm | 25 Jan 2023 | Business Standard

Firm says sustained focus on improving productivity has also helped boost profits; DRL is now bullish on its biosimilars and hopes to start filing for...
Torrent Pharma Q3 net profit up 14% to Rs 283 cr; interim dividend declared

6.26 pm | 25 Jan 2023 | Press Trust of India

Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to Rs 283 crore in the third quarter ended December 31, 2022. T...
Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US

5.44 pm | 25 Jan 2023 | Business Standard

Revenue up 6% to Rs 5,810 cr; firm expects US FDA audit at Goa unit
Lupin Digital launches Lyfe, a 24x7 monitoring ecosystem for heart patients

8.35 pm | 24 Jan 2023 | Business Standard

Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and offline mo...
Sun Pharma to acquire US-based Concert Pharmaceuticals for $576 million

10.09 pm | 19 Jan 2023 | Business Standard

Deal size could expand to $827 mn if additional milestone-based payments are made
Cipla launches diagnostic device, says it will provide results in minutes

11.55 am | 18 Jan 2023 | Business Standard

Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility
Lupin gets USFDA tentative nod for generic drugs to treat HIV infection

12.14 am | 17 Jan 2023 | Press Trust of India

Pharmaceutical firm Lupin on Monday said it has received tentative approval from the US health regulator to market its generic version of Dolutegravir...
Breather for Natco in Novartis cardiac drug case from Delhi High Court

9.33 pm | 15 Jan 2023 | Business Standard

May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week
Breather for Natco in Novartis cardiac drug case from Delhi High Court

9.33 pm | 15 Jan 2023 | Business Standard

May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week
RIL, Dr Reddy's Labs: 5 Nifty500 stocks cross 200-DMA, defying weak trend

11.48 am | 10 Jan 2023 | Business Standard

Following a strong close over the 200-DMA set at Rs 2,559, the chart structure of Reliance Industries reveals a "Double Bottom" breakout